✦ LIBER ✦

Congenital nystagmus: Randomized, controlled, double-masked trial of memantine/gabapentin

✍ Scribed by Rebecca McLean; Frank Proudlock; Shery Thomas; Chris Degg; Irene Gottlob

Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 325 KB
Volume: 61
Category: Article
ISSN: 0364-5134
DOI: 10.1002/ana.21065

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gabapentin in the treatment of fibromyal

Gabapentin in the treatment of fibromyalgia: A randomized, double-blind, placebo-controlled, multicenter trial

✍ Lesley M. Arnold; Don L. Goldenberg; Sharon B. Stanford; Justine K. Lalonde; H. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB 👁 3 views

## Abstract ## Objective To assess the efficacy and safety of gabapentin in patients with fibromyalgia. ## Methods A 12‐week, randomized, double‐blind study was designed to compare gabapentin (1,200–2,400 mg/day) (n = 75 patients) with placebo (n = 75 patients) for efficacy and safety in treatin

Gabapentin in patients with the pruritus

Gabapentin in patients with the pruritus of cholestasis: A double-blind, randomized, placebo-controlled trial

✍ Nora V. Bergasa; Monnie McGee; Iona H. Ginsburg; Danielle Engler 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 420 KB 👁 2 views

Pruritus is defined as the second order of nociception, the first being pain; thus, there is a rationale to study gabapentin, a drug that increases the threshold to experience nociception. The aim of this double-blind, randomized, placebo-controlled trial was to study the effect of gabapentin on the

A randomized, placebo-controlled, double

A randomized, placebo-controlled, double-masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis

✍ Smith, Janine A. ;Thompson, Darby J. S. ;Whitcup, Scott M. ;Suhler, Eric ;Clarke 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB 👁 2 views

Efficacy of gabapentin in the management

Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy : A phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3)

✍ Ravi D. Rao; John C. Michalak; Jeff A. Sloan; Charles L. Loprinzi; Gamini S. Soo 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 228 KB 👁 2 views

## Abstract ## BACKGROUND. The antiepileptic agent, gabapentin, has been demonstrated to relieve symptoms of peripheral neuropathy due to various etiologies. On the basis of these data, a multicenter, double‐blind, placebo‐controlled, crossover, randomized trial was conducted to evaluate the effec